繁體版 / 簡體版
 
R&D PORTFOLIO
/ HERBIRON

HERBIRON

Indication
Relieving symptoms of iron deficiency anemia and menstrual discomfort
Ingredient
Si Wu (Rehmanniae Radix, Chuanxiong Rhizoma, Angelicae Sinensis Radix, Paeonia Alba Radix) plus ferrous Bisglycinate
Dosage
50 ml twice daily on an empty stomach before meals
Product Advantages
Significantly elevate Hemoglobin, Mean corpuscular volume and Serum ferritin
Status
Post-market drug
  • Herbiron in accordance with the concept of Chinese and Western cultures, is composed of Chinese herbal medicine and well-known study ferrous Bisglycinate.
  • Ferrous Bisglycinate is easily absorbed by the body, can increase iron utilization, more than other iron supplements.
  • Herbiron was approved as new drug by Ministry of Health and Welfare (MOHW) in 2013
  • The clinical efficacy of Herbiron was confirmed in a phase III trial. Herbiron significantly improved the anemia symptoms caused by iron deficiency in premenopausal females and relieved Dysmenorrhea.
  • The safety of Herbiron was confirmed in a phase III trial. The incidence of gastrointestinal side effects in subjects treated with Herbiron was significantly reduced when compared to that in subjects treated with ferrous sulfate.

Phase III Clinical Results

Serum ferritin, Hemoglobin and the Mean corpuscular volume concentration increased significantly over time as compared to baseline (before drug use) (* p <0.0001)


体彩p5中奖新闻 浙江11选5高频500彩票 中彩网app下载 大公鸡排列五 重庆快乐10分开奖数据 天津11选五5开奖电脑版走势图 配资炒股合法吗 北京快3开奖l结果查询天上海快三开奖结果 体育彩票七星彩规则 云南快乐10分开奖结果一定彩牛 2008上证指数最高